DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Young G, Liesner R, Chang T, Sidonio R. et al.
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Blood 2019 Dec 12;134(24):2127–2138. Doi: 10.1182/blood.2019001869. PMID: 31697801; PMCID: PMC6908828
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.